Skip to Content

W 925 (ENALAPRIL 10 mg)

Pill imprint W 925 has been identified as Enalapril maleate 10 mg.

Enalapril is used in the treatment of high blood pressure; diabetic kidney disease; heart failure; hypertensive emergency; left ventricular dysfunction (and more), and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy. Enalapril 10 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).

Enalapril maleate 10 mg W 925
Enalapril maleate 10 mg W 925  Front
Enalapril maleate 10 mg W 925  Back
Enalapril maleate 10 mg W 925
Enalapril maleate
W 925
10 mg
8.00 mm
Prescription only
Drug Class:
Angiotensin converting enzyme inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Wockhardt USA
National Drug Code (NDC):
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
00172-4197 Ivax Pharmaceuticals Inc
00904-5610 Major Pharmaceuticals
68084-0391 Amerisource Health Services
63304-0836 Ranbaxy Pharmaceuticals Inc.
63874-0655 Altura Pharmaceuticals Inc (repackager)
54569-5134 A-S Medication Solutions, LLC (repackager)
21695-0488 Rebel Distributors Corp (repackager)
54868-4358 Physicians Total Care Inc (repackager)
33358-0127 CorePharma, LLC (repackager)
23490-5491 Palmetto State Pharmaceuticals Inc (repackager)
66336-0389 Dispensing Solutions Inc. (repackager)
68115-0127 Dispensexpress Inc (repackager)
66267-1009 Nucare Pharmaceuticals Inc (repackager)
67544-0216 Prepak Systems Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2015, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.